Kayan Ventures is an early-stage venture fund with a global remit, focusing on HealthTech and ClimateTech companies. They invest in deep tech, data-driven, and AI-powered companies that are working on novel and essential technologies with early signs of delivering value to the markets that need them. Their mission is to enhance and improve the quality of life through their investments. The firm looks for companies that are innovatively and positively disruptive, indicating a focus on ventures with the potential to significantly impact their respective industries. This suggests a willingness to take risks on companies with high growth potential and the capacity to address critical global challenges. In HealthTech, Kayan Ventures targets medical devices, life sciences & longevity, artificial intelligence & machine learning applications, health data analytics & digital therapeutics, and preventative medicine & early diagnostics. In ClimateTech, they focus on battery technology & EV adoption, precision agriculture & sustainable farming, analytics & IoT, built environment & sustainable materials, and food & water security. They prioritize investments that can contribute to mitigating climate change, promoting sustainability, and improving healthcare delivery and patient outcomes. Their portfolio strategy emphasizes a global perspective, suggesting they are open to investing in companies from diverse geographic locations. By combining a focus on deep tech with specific sector expertise in HealthTech and ClimateTech, Kayan Ventures aims to identify and support companies that can generate both financial returns and positive social impact.
Bevorzugte Reifephase für die erste Finanzierung.
HealthTech, ClimateTech, Deep Tech, AI, Data-Driven Technologies
Thematische Schwerpunkte und Zielmarktsegmente von Interesse.
Standard-Finanzierungsbetrag pro Runde.
Verifiziertes E-Mail-Muster
Analysen-Scorecard der Investitionsthese
Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...
